High Blood Pressure Strategy: Hypertension Management Initiative Study
This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure. The High Blood Pressure Strategy brings together healthcare providers and patients to improve the way in which family doctors, nurse practitioners and pharmacists work together and with patients towards improved control of high blood pressure through the use of evidence-informed tools combined with local systems change.
Description
Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario. Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later. The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient. Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient’s blood pressure.
Status: Recruiting (N/A). Started on January 1st, 2007. Ended on January 1st, 2010.
Enrollment: 5000 subjects
Study Type: Interventional
Study Design:
- Other
- Randomized
- Open Label
- Active Control
- Parallel Assignment
- Efficacy Study
Conditions:
Interventions:
- Behavioral: Systems Change (High Blood Pressure Strategy)
Eligibility
Inclusion Criteria:
Adults aged 18 years or older
History of elevated BP reading or primary hypertension diagnosis
Exclusion Criteria:
Major mental health illness of cognitive impairment
Language barrier (unable to speak or read English)
Lives in a long-term care home
Secondary hypertension
- Gender
Both
- Mininum Age
18 Years
- Maximum Age
N/A
- Healthy Volunteers
No
Resources
Source: Heart and Stroke Foundation of Ontario
Authority: Canada: Ethics Review Committee
Locations
-
Heart and Stroke Foundation of Ontario
Toronto
Ontario
M4P1E4
Canada
Officials
Sheldon W Tobe, MD, FRCP(C) (Principal Investigator, Sunnybrook Health Sciences Centre)
Margaret Moy Lum-Kwong, BSc.N., MBA, CHE (Principal Investigator, Heart and Stroke Foundation of Ontario)
Shirley Von Sychowski, BA, MA (Principal Investigator, Heart and Stroke Foundation of Ontario)
Sponsors
Heart and Stroke Foundation of Ontario (Lead Sponsor)
Sunnybrook Health Sciences Centre (Collaborator)
References
None.
Links
None.
- Date Verified
- August 1st, 2008
- First Received
- August 18th, 2008
- Last Changed
- August 18th, 2008
Information obtained from ClinicalTrials.gov on August 20, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.